Tech Company Financing Transactions

VentiRx Pharmaceuticals Funding Round

VentiRx Pharmaceuticals secured a $28.9 million Series A financing round on 3/6/2007. Investors included Frazier Healthcare Partners, Arch Venture Partners and Domain Associates.

Transaction Overview

Announced On
3/6/2007
Transaction Type
Venture Equity
Amount
$28,900,000
Round
Series A
Investors

Frazier Healthcare Partners (Lead Investor) (Patrick Heron)

Arch Venture Partners (Steven Gillis)

Domain Associates (Nicole Vitullo)

Proceeds Purpose
The Company expects to use the funds to build a portfolio of product candidates with an initial focus on small molecule Toll-like receptor (TLR)-based therapeutics.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1191 Second Ave. 1105
Seattle, WA 98101
USA
Email Address
Overview
VentiRx Pharmaceuticals, Inc. is a biopharmaceutical company committed to the development of novel medicines for the treatment of cancer, infectious, respiratory, and autoimmune diseases.
Profile
VentiRx Pharmaceuticals LinkedIn Company Profile
Social Media
VentiRx Pharmaceuticals Company Twitter Account
Company News
VentiRx Pharmaceuticals News
Facebook
VentiRx Pharmaceuticals on Facebook
YouTube
VentiRx Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Robert Hershberg
  Robert Hershberg LinkedIn Profile  Robert Hershberg Twitter Account  Robert Hershberg News  Robert Hershberg on Facebook
Chief Medical Officer
James Bryan
  James Bryan LinkedIn Profile  James Bryan Twitter Account  James Bryan News  James Bryan on Facebook
Chief Operating Officer
Kathleen Fanning
  Kathleen Fanning LinkedIn Profile  Kathleen Fanning Twitter Account  Kathleen Fanning News  Kathleen Fanning on Facebook
VP - Finance
Tom Swallow
  Tom Swallow LinkedIn Profile  Tom Swallow Twitter Account  Tom Swallow News  Tom Swallow on Facebook
VP - R & D
Gregory Dietsch
  Gregory Dietsch LinkedIn Profile  Gregory Dietsch Twitter Account  Gregory Dietsch News  Gregory Dietsch on Facebook
VP - Regulatory Affairs
Tressa Randall
  Tressa Randall LinkedIn Profile  Tressa Randall Twitter Account  Tressa Randall News  Tressa Randall on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/6/2007: Calistoga Pharmaceuticals venture capital transaction
Next: 3/6/2007: PneumRx venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on funding rounds that are announced publicly. VC investment data records reported here come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary